The exposure of subcutaneous tissue following a loss of skin integrity provides a moist, warm, and nutrient-rich environment for microbial colonisation and proliferation. Accordingly, the use of tropical antimicrobial agents is crucial for the management of surgical site infections (SSIs) and chronic wounds, including venous stasis ulcers, diabetic foot ulcers, pressure ulcers, burns, and fungating lesions.
By virtue of their mode of action, hypochlorous acid (HOCl) cleansers offer a safe, effective, and potentially cost-effective solution to managing bioburden, reducing healing times in chronic and septic wounds, and – most importantly – improving the quality of life for patients with chronic wounds.
These game-changing cleansers boast a wealth of clinical benefits:
